Rodman & Renshaw Downgrades ABIOMED (ABMD) to Market Underperform
Tweet
Share
E-mailGet Alerts ABMD Hot Sheet
Price: $381.02 --0%
Rating Summary:
7 Buy, 12 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 12 | New: 26
Rating Summary:
7 Buy, 12 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 12 | New: 26
Join SI Premium – FREE
Rodman & Renshaw downgraded ABIOMED (NASDAQ: ABMD) from Market Perform to Market Underperform with a price target of $13.00.
For an analyst ratings summary and ratings history on ABIOMED click here. For more ratings news on ABIOMED click here.
Shares of ABIOMED closed at $19.25 yesterday.
For an analyst ratings summary and ratings history on ABIOMED click here. For more ratings news on ABIOMED click here.
Shares of ABIOMED closed at $19.25 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel Downgrades Weave Communications Inc (WEAV) to Hold
- Baird Downgrades Ramaco Resources Inc. (METC) to Neutral
- Berenberg Downgrades Segro PLC (SGRO:LN) (SEGXF) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Rodman & RenshawSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
